New Article – Pharmaceutical & Biotech Lifecycle Management (I)

I recently put together a pilot study to test some views on the factors
which affect success in the ongoing war between ‘innovator’ and
‘generic’ companies. In this, the first in a series of articles, I look
at one of the interesting (but expected) outcomes from the study – that
over time, generic companies have become better at getting on to the
market earlier. To comment on this article, please go to the equivalent
blog post on my site. If you are reading the blog, then you can read
the full article in the article section of the site.

Read the article

%d bloggers like this: